When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data
Pulley, Jill M., Jerome, Rebecca N., Zaleski, Nicole M., Shirey-Rice, Jana K., Pruijssers, Andrea J., Lavieri, Robert R., Chettiar, Somsundaram N., Naylor, Helen M., Aronoff, David M., Edwards, DavidLanguage:
english
Journal:
ASSAY and Drug Development Technologies
DOI:
10.1089/adt.2017.821
Date:
December, 2017
File:
PDF, 380 KB
english, 2017